US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvectis Pharma, Inc.

8.96

-0.4100-4.38%

Post-market: 8.960.00000.00%18:52 EDT

Volume:298.14K

Turnover:2.58M

Market Cap:209.59M

PE:-8.07

High:9.61

Open:9.60

Low:8.01

Close:9.37

Loading ...

Overview Company News Filings

Nuvectis Pharma Q1 EPS $(0.27) Misses $(0.25) Estimate

BRIEF-Nuvectis Pharma Q1 Net Income USD -5.332 Million

Nuvectis Pharma Q1 EPS USD -0.27

THOMSON REUTERS

Nuvectis Pharma Inc: Extending Projected Cash Runway Into 1Q2027

THOMSON REUTERS

Press Release: Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Buy Rating for Nuvectis Pharma: Promising Phase 1 Trial Results of NXP900 Highlight Potential in Combination Therapies

Nuvectis Pharma Price Target Raised to $15.00/Share From $11.00 by HC Wainwright & Co.

Promising Developments in Nuvectis Pharma’s NXP900 Drive Buy Rating

Nuvectis Pharma, Inc. : H.c. Wainwright Raises Target Price to $15 From $11

THOMSON REUTERS

Why Nuvectis Pharma, Inc. (NVCT) is Surging in 2025

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting

Nuvectis Pharma Initiated at Buy by Maxim Group

Maxim Initiates Nuvectis Pharma at Buy With $17 Price Target

MT Newswires Live

Nuvectis Pharma Inc : Maxim Group Initiates Coverage With Buy Rating; Price Target $17

THOMSON REUTERS

Nuvectis Pharma Announces Upcoming Presentations for Nxp900 at the 2025 American Association for Cancer Research Meeting

THOMSON REUTERS

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation

Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC

Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets

Nuvectis Pharma Is Maintained at Buy by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVCT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","market":"US","secType":"STK","nameCN":"Nuvectis Pharma, Inc.","latestPrice":8.96,"timestamp":1746561600000,"preClose":9.37,"halted":0,"volume":298139,"hourTrading":{"tag":"盘后","latestPrice":8.96,"preClose":8.96,"latestTime":"18:52 EDT","volume":15,"amount":138.64,"timestamp":1746571975123},"delay":0,"floatShares":12768280,"shares":23391499,"eps":-1.110256,"marketStatus":"Closed","change":-0.41,"latestTime":"05-06 16:00:00 EDT","open":9.6,"high":9.6148,"low":8.008,"amount":2582315.599983,"amplitude":0.171483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.110256,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":5,"adr":0,"listingDate":1638334800000,"exchange":"NASDAQ","adjPreClose":9.37,"preHourTrading":{"tag":"盘前","latestPrice":9.51,"preClose":9.37,"latestTime":"08:00 EDT","volume":2198,"amount":21911.879584000002,"timestamp":1746532800672},"postHourTrading":{"tag":"盘后","latestPrice":8.96,"preClose":8.96,"latestTime":"18:52 EDT","volume":15,"amount":138.64,"timestamp":1746571975123},"volumeRatio":1.837393,"impliedVol":1.2206,"impliedVolPercentile":0.3298},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","floatShares":12768280,"roa":"-65.65%","roe":"-173.41%","lyrEps":-1.110256,"volumeRatio":1.837393,"shares":23391499,"dividePrice":0,"high":9.6148,"amplitude":0.171483,"preClose":9.37,"low":8.008,"week52Low":4.44,"pbRate":"21.58","week52High":11.8,"institutionHeld":0,"latestPrice":8.96,"eps":-1.110256,"divideRate":0,"volume":298139,"delay":0,"ttmEps":-1.110256,"open":9.6,"prevYearClose":5.41,"prevWeekClose":9.25,"prevMonthClose":9.96,"prevQuarterClose":9.77,"fiveDayClose":10.33,"twentyDayClose":8.24,"sixtyDayClose":6.71},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVCT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533868725","title":"Nuvectis Pharma Q1 EPS $(0.27) Misses $(0.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533868725","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533868725?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:03","pubTimestamp":1746532987,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 8 percent decrease over losses of $(0.25) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45219078/nuvectis-pharma-q1-eps-0-27-misses-0-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"gpt_icon":0},{"id":"2533687496","title":"BRIEF-Nuvectis Pharma Q1 Net Income USD -5.332 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533687496","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533687496?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532856,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvectis Pharma Q1 Net Income USD -5.332 Million\n\n\nMay 06 (Reuters) - Nuvectis Pharma Q1 EPS USD -0.27.\n\nQ1 operating income USD -5.568 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLXDB14DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2533687942","title":"Nuvectis Pharma Q1 EPS USD -0.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2533687942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533687942?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532811,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLXDB14DB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2533668039","title":"Nuvectis Pharma Inc: Extending Projected Cash Runway Into 1Q2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2533668039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533668039?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532811,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLXDB14DB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2533268082","title":"Press Release: Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2533268082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533268082?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532800,"startTime":"0","endTime":"0","summary":"-- NXP900 clinical data presentation from the Phase 1a dose escalation study. at the 2025 American Association for Cancer Research  conference. demonstrated robust pharmacodynamic response and acceptable safety at. Cash and cash equivalents were $29.9 million as of March 31, 2025, compared to $18.5 million as of December 31, 2024. The increase of $11.4 million in cash balance in the first quarter of 2025 is a result of the Company's public offering in February 2025 with net proceeds of $14.0 million, after transaction fees and expenses, and the utilization of the at-the-market facility, partial","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2532716886","title":"Buy Rating for Nuvectis Pharma: Promising Phase 1 Trial Results of NXP900 Highlight Potential in Combination Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2532716886","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532716886?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:45","pubTimestamp":1746121514,"startTime":"0","endTime":"0","summary":"Analyst Naz Rahman of Maxim Group maintained a Buy rating on Nuvectis Pharma (NVCT – Research Report), retaining the price target of $17.00. Naz Ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-nuvectis-pharma-promising-phase-1-trial-results-of-nxp900-highlight-potential-in-combination-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-nuvectis-pharma-promising-phase-1-trial-results-of-nxp900-highlight-potential-in-combination-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"gpt_icon":0},{"id":"2531364770","title":"Nuvectis Pharma Price Target Raised to $15.00/Share From $11.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2531364770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531364770?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:48","pubTimestamp":1746013680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NVCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2025 07:48 ET (11:48 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"gpt_icon":0},{"id":"2531082393","title":"Promising Developments in Nuvectis Pharma’s NXP900 Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2531082393","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531082393?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:16","pubTimestamp":1746008185,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Nuvectis Pharma (NVCT – Research Report) today and set a price target of $15.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-nuvectis-pharmas-nxp900-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-nuvectis-pharmas-nxp900-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"gpt_icon":0},{"id":"2531081576","title":"Nuvectis Pharma, Inc. : H.c. Wainwright Raises Target Price to $15 From $11","url":"https://stock-news.laohu8.com/highlight/detail?id=2531081576","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531081576?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:06","pubTimestamp":1746007606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nAZN3RSS25:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2531908518","title":"Why Nuvectis Pharma, Inc. (NVCT) is Surging in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531908518","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531908518?lang=en_us&edition=fundamental","pubTime":"2025-04-30 17:28","pubTimestamp":1746005284,"startTime":"0","endTime":"0","summary":"We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Nuvectis Pharma Inc  stands against other healthcare stocks that are surging in 2025.After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year. Healthcare spending has been continuously soaring and is projected to do so in the coming years due to demographic tailwinds. The industry now accounts for a fifth of the U.S. economy, and it’s a good idea to have exposure to it.Most executives now hold a favorable view of the industry’s prospects, a notable increase from 52% just a year ago. Moreover, it’s an industry that is more insulated from tariffs and macro risks.Of course, the top gainers here are not defensive healthcare stocks, but it’s still worth looking into the winners here if you are chasing potential multibaggers.Even during bear markets, there are pockets of the market that perform exceptionally w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-nuvectis-pharma-inc-nvct-092804762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","TQQQ","TSYW.SI","USAW.SI","QID",".IXIC","NVIW.SI","NQmain","NVCT","QLD","USJW.SI","BK4139","PSQ","MNQmain"],"gpt_icon":1},{"id":"2531979677","title":"Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531979677","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531979677?lang=en_us&edition=fundamental","pubTime":"2025-04-30 04:25","pubTimestamp":1745958300,"startTime":"0","endTime":"0","summary":"Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an acceptable safety profile, dose limiting toxicity dose level has not been identified in doses up to 250 mg/day. Preclinical posters strengthen the NXP900 clinical development strategy as single agent in biomarker-targeted cancers and in combination with market leading therapies to overcome resistance in NSCLC. As a combination partner, the addition of NXP900 to market leading epidermal growth factor receptor  and anaplastic lymphoma kinase  kinase inhibitors resulted in reversal of resistance to the anti-EGFR and anti-ALK agents, providing the scientific rationale for th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nuvectis-pharma-provides-poster-presentation-202500923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4500","ALK","BK4585","BK4139","BK4008","BK4588","NVCT"],"gpt_icon":0},{"id":"2524145754","title":"Nuvectis Pharma Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145754?lang=en_us&edition=fundamental","pubTime":"2025-04-03 01:24","pubTimestamp":1743614640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NVCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2025 13:24 ET (17:24 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2524182934","title":"Maxim Initiates Nuvectis Pharma at Buy With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2524182934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524182934?lang=en_us&edition=fundamental","pubTime":"2025-04-02 23:26","pubTimestamp":1743607606,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma (NVCT) has an average rating of buy and mean price target of $17, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVCT"],"gpt_icon":0},{"id":"2524464653","title":"Nuvectis Pharma Inc : Maxim Group Initiates Coverage With Buy Rating; Price Target $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2524464653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524464653?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:42","pubTimestamp":1743594173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QG0W3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2522871081","title":"Nuvectis Pharma Announces Upcoming Presentations for Nxp900 at the 2025 American Association for Cancer Research Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522871081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522871081?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:00","pubTimestamp":1742990403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA7MMRWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2519809873","title":"Nuvectis Pharma to Participate in the 37th Annual Roth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2519809873","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519809873?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:00","pubTimestamp":1741953600,"startTime":"0","endTime":"0","summary":"Ron Bentsur Chairman, Chief Executive Officer and President  rbentsur@nuvectis.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nuvectis-pharma-participate-37th-annual-120000149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2517691282","title":"Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2517691282","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517691282?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:44","pubTimestamp":1741182240,"startTime":"0","endTime":"0","summary":"Cleveland Clinic research provides further positive validation Nuvectis Pharma's* NXP900 cancer-fighting potential, showing enhanced efficacy when combined with AstraZeneca's blockbuster drug Tagrisso in EGFR+ lung cancer models. New $18 price target and buy recommendation from Lucid Capital Markets implies 200%+ potential upside as Phase 1b trial approaches. NEW YORK, March 05, 2025----Market News Alerts Reports: Nuvectis Pharma * announced today that new independent research conducted at the Lerner Research Institute, Cleveland Clinic  has demonstrated the superior efficacy of NXP900 when combined with osimertinib  in EGFR-mutated non-small cell lung cancer  models. The peer-reviewed study, published in Molecular Cancer Research, demonstrated that the combination therapy led to decreased cancer cell proliferation and increased apoptosis compared to osimertinib alone.Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/market-news-alert-nuvectis-pharma-134400714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2516757996","title":"Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2516757996","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516757996?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"Research conducted at the Lerner Research Institute, Cleveland Clinic . Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis, commented, “As we continue our activities toward the initiation of the Phase 1b program of NXP900, we are very pleased to see yet another independently generated dataset from a highly reputable research institution demonstrating the synergistic effect of adding NXP900 to osimertinib in EGFR mutated NSCLC. With the Phase 1a dose escalation study nearing completion, we are excited about the potential opportunities presented by NXP900 in therapeutic areas of unmet medical need, both as a single agent and in combination with market-leading anti-cancer drugs.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nuvectis-pharma-announces-publication-research-130000051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVCT"],"gpt_icon":0},{"id":"2514087382","title":"Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2514087382","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514087382?lang=en_us&edition=fundamental","pubTime":"2025-02-27 23:43","pubTimestamp":1740670980,"startTime":"0","endTime":"0","summary":"Precision oncology player Nuvectis Pharma receives a buy recommendation and price target with a significant premium from Lucid Capital Markets. Report highlights Nuvectis’ potential to generate hundreds of millions of dollars in revenue and notes upcoming phase 1a clinical data as a potential catalyst. NEW YORK, February 27, 2025----Market News Alerts Reports: Lucid Capital Markets has initiated coverage on Nuvectis Pharma  with a Buy rating and a price target of $18. The firm's report highlights Nuvectis' promising oncology pipeline, particularly its lead asset, NXP900, a SRC/YES1 inhibitor targeting squamous cell carcinomas with high unmet need.Lucid's report emphasizes the strong potential of NXP900, which is currently in Phase 1 clinical trials and has shown an encouraging safety profile while continuing dose escalation. The firm projects peak non-risk-adjusted sales of over $900 million for NXP900 across multiple cancer indications by 2041.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/market-news-alert-nuvectis-pharma-154300160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVCT"],"gpt_icon":1},{"id":"2514014665","title":"Nuvectis Pharma Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2514014665","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514014665?lang=en_us&edition=fundamental","pubTime":"2025-02-26 00:57","pubTimestamp":1740502620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NVCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2025 11:57 ET (16:57 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVCT\",params:#limit:5,,,undefined,":[{"date":"2025-05-06","symbol":"NVCT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.3,"defaultRemindTime":1746518400000,"name":null,"time":"Pre-Market","dateTimestamp":1746504000000,"actualEps":null},{"market":"US","date":"2025-02-25","symbol":"NVCT","fiscalQuarterEnding":"2024/12","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2024-11-05","symbol":"NVCT","fiscalQuarterEnding":"2024/09","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-08-06","symbol":"NVCT","fiscalQuarterEnding":"2024/06","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-05-07","symbol":"NVCT","fiscalQuarterEnding":"2024/03","expectedEps":-0.4,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":-0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVCT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVCT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVCT","date":"2025-05-05","current":-11.387967,"percent":0.191816,"low":-4822.163542,"twenty":-11.229851,"median":-7.810268,"eighty":-5.880092,"high":-4.507629,"avg":-158.595796,"sd":728.627164,"marketCap":216371365},"quantilePoints":[{"date":"2022-02-04","current":-1722.20125,"twenty":-2416.901458,"median":-2416.901458,"eighty":-2000.081333,"marketCap":41332830},{"date":"2022-02-11","current":-3677.562083,"twenty":-3582.178633,"median":-3306.626438,"eighty":-2416.901458,"marketCap":88261490},{"date":"2022-02-18","current":-3105.261333,"twenty":-3521.769108,"median":-3195.345708,"eighty":-2596.861958,"marketCap":74526272},{"date":"2022-02-25","current":-3359.617208,"twenty":-3425.325841,"median":-3227.140208,"eighty":-2883.759766,"marketCap":80630813},{"date":"2022-03-04","current":-3990.207833,"twenty":-3634.109608,"median":-3354.318146,"eighty":-2982.322667,"marketCap":95764988},{"date":"2022-03-11","current":-4382.339833,"twenty":-4096.189467,"median":-3439.103458,"eighty":-3123.278208,"marketCap":105176156},{"date":"2022-03-18","current":-4149.180292,"twenty":-4143.881209,"median":-3592.776792,"eighty":-3195.345708,"marketCap":99580327},{"date":"2022-03-25","current":-7.409669,"twenty":-4111.026892,"median":-3439.103458,"eighty":-2883.759766,"marketCap":95510632},{"date":"2022-04-01","current":-6.926215,"twenty":-4060.1557,"median":-3354.318146,"eighty":-350.415344,"marketCap":89278913},{"date":"2022-04-08","current":-9.323751,"twenty":-4037.899584,"median":-3227.140208,"eighty":-8.266073,"marketCap":120183153},{"date":"2022-04-14","current":-9.965067,"twenty":-4016.70325,"median":-3195.345708,"eighty":-8.337111,"marketCap":128449719},{"date":"2022-04-22","current":-9.550678,"twenty":-3990.207833,"median":-3028.424667,"eighty":-9.234954,"marketCap":123108245},{"date":"2022-04-29","current":-9.373083,"twenty":-3905.422542,"median":-2416.901458,"eighty":-9.234954,"marketCap":120819043},{"date":"2022-05-06","current":-17.956854,"twenty":-3677.562083,"median":-870.079052,"eighty":-9.234954,"marketCap":231463850},{"date":"2022-05-13","current":-15.163214,"twenty":-3640.4685,"median":-14.858803,"eighty":-9.323751,"marketCap":239730416},{"date":"2022-05-20","current":-12.468425,"twenty":-3608.674042,"median":-15.011008,"eighty":-9.373083,"marketCap":197125807},{"date":"2022-05-27","current":-12.597132,"twenty":-3576.879542,"median":-14.366844,"eighty":-9.373083,"marketCap":199160654},{"date":"2022-06-03","current":-9.773637,"twenty":-3517.529842,"median":-13.793232,"eighty":-9.396762,"marketCap":154521197},{"date":"2022-06-10","current":-9.652975,"twenty":-3451.82125,"median":-12.774103,"eighty":-9.410576,"marketCap":152613528},{"date":"2022-06-17","current":-8.824428,"twenty":-3383.992992,"median":-12.70975,"eighty":-9.363217,"marketCap":139514200},{"date":"2022-06-24","current":-9.242723,"twenty":-3363.856475,"median":-12.468425,"eighty":-9.239615,"marketCap":146127453},{"date":"2022-07-01","current":-9.64493,"twenty":-3353.258333,"median":-11.474627,"eighty":-9.239615,"marketCap":152486350},{"date":"2022-07-08","current":-10.224109,"twenty":-3315.104967,"median":-10.465433,"eighty":-9.275134,"marketCap":161643161},{"date":"2022-07-15","current":-9.086265,"twenty":-3249.396358,"median":-10.409124,"eighty":-9.258683,"marketCap":143653842},{"date":"2022-07-22","current":-9.586449,"twenty":-3214.422408,"median":-10.216065,"eighty":-9.238062,"marketCap":151561766},{"date":"2022-07-29","current":-7.078848,"twenty":-3195.345708,"median":-9.9848,"eighty":-9.113213,"marketCap":111916587},{"date":"2022-08-05","current":-8.052111,"twenty":-3195.345708,"median":-9.910387,"eighty":-8.975658,"marketCap":108228426},{"date":"2022-08-12","current":-9.488582,"twenty":-3159.311958,"median":-9.805813,"eighty":-8.932791,"marketCap":127536026},{"date":"2022-08-19","current":-9.793611,"twenty":-3043.792,"median":-9.810606,"eighty":-8.975658,"marketCap":131635922},{"date":"2022-08-26","current":-9.510369,"twenty":-2917.673883,"median":-9.781681,"eighty":-9.015878,"marketCap":127828876},{"date":"2022-09-02","current":-9.031038,"twenty":-2686.842208,"median":-9.757814,"eighty":-8.975658,"marketCap":121386184},{"date":"2022-09-09","current":-9.150871,"twenty":-2416.901458,"median":-9.745482,"eighty":-8.964396,"marketCap":122996857},{"date":"2022-09-16","current":-8.932993,"twenty":-2277.961416,"median":-9.701239,"eighty":-8.937021,"marketCap":120068360},{"date":"2022-09-23","current":-8.573495,"twenty":-1381.352371,"median":-9.632337,"eighty":-8.826532,"marketCap":115236341},{"date":"2022-09-30","current":-7.723771,"twenty":-17.65393,"median":-9.586518,"eighty":-8.651931,"marketCap":103815204},{"date":"2022-10-07","current":-7.63662,"twenty":-16.210562,"median":-9.563205,"eighty":-8.405729,"marketCap":102643805},{"date":"2022-10-14","current":-7.603938,"twenty":-15.261352,"median":-9.524268,"eighty":-8.26218,"marketCap":102204531},{"date":"2022-10-21","current":-7.680195,"twenty":-15.169649,"median":-9.483135,"eighty":-8.073594,"marketCap":103229505},{"date":"2022-10-28","current":-7.810268,"twenty":-15.102332,"median":-9.471747,"eighty":-7.885,"marketCap":104977817},{"date":"2022-11-04","current":-7.576703,"twenty":-14.768455,"median":-9.451943,"eighty":-7.747738,"marketCap":101838469},{"date":"2022-11-11","current":-6.796511,"twenty":-14.399021,"median":-9.402682,"eighty":-7.680195,"marketCap":99568884},{"date":"2022-11-18","current":-7.224291,"twenty":-14.29948,"median":-9.348417,"eighty":-7.640977,"marketCap":105835867},{"date":"2022-11-25","current":-7.26627,"twenty":-14.030026,"median":-9.293004,"eighty":-7.625726,"marketCap":106450851},{"date":"2022-12-02","current":-7.506147,"twenty":-13.793232,"median":-9.25981,"eighty":-7.576703,"marketCap":109965047},{"date":"2022-12-09","current":-7.506147,"twenty":-12.999339,"median":-9.210288,"eighty":-7.516141,"marketCap":109965047},{"date":"2022-12-16","current":-7.406198,"twenty":-12.782147,"median":-9.150762,"eighty":-7.496152,"marketCap":108500799},{"date":"2022-12-23","current":-7.738527,"twenty":-12.766059,"median":-9.1187,"eighty":-7.454973,"marketCap":113369424},{"date":"2022-12-30","current":-7.496152,"twenty":-12.766059,"median":-9.099176,"eighty":-7.44634,"marketCap":109818622},{"date":"2023-01-06","current":-7.594801,"twenty":-12.732274,"median":-9.091333,"eighty":-7.450405,"marketCap":111263835},{"date":"2023-01-13","current":-7.406198,"twenty":-12.642179,"median":-9.041932,"eighty":-7.450257,"marketCap":108500799},{"date":"2023-01-20","current":-7.496152,"twenty":-12.545649,"median":-9.025531,"eighty":-7.451274,"marketCap":109818622},{"date":"2023-01-27","current":-7.975905,"twenty":-12.317195,"median":-8.981288,"eighty":-7.451274,"marketCap":116847014},{"date":"2023-02-03","current":-10.369677,"twenty":-11.855901,"median":-9.025531,"eighty":-7.452843,"marketCap":151915761},{"date":"2023-02-10","current":-14.362627,"twenty":-11.979785,"median":-9.058273,"eighty":-7.455453,"marketCap":210412480},{"date":"2023-02-17","current":-9.964884,"twenty":-11.831926,"median":-9.096402,"eighty":-7.46125,"marketCap":145985555},{"date":"2023-02-24","current":-10.434643,"twenty":-11.751993,"median":-9.101951,"eighty":-7.472325,"marketCap":152867522},{"date":"2023-03-03","current":-11.973853,"twenty":-11.789947,"median":-9.134127,"eighty":-7.486157,"marketCap":175416946},{"date":"2023-03-10","current":-8.326972,"twenty":-11.789947,"median":-9.107295,"eighty":-7.488136,"marketCap":158920261},{"date":"2023-03-17","current":-9.237161,"twenty":-11.658015,"median":-9.099176,"eighty":-7.496072,"marketCap":176291215},{"date":"2023-03-24","current":-9.086429,"twenty":-11.512116,"median":-9.107295,"eighty":-7.496152,"marketCap":173414497},{"date":"2023-03-31","current":-10.133823,"twenty":-11.492386,"median":-9.134127,"eighty":-7.496152,"marketCap":193404003},{"date":"2023-04-06","current":-9.75506,"twenty":-11.456868,"median":-9.150762,"eighty":-7.496152,"marketCap":186175325},{"date":"2023-04-14","current":-11.478815,"twenty":-11.451785,"median":-9.210288,"eighty":-7.496152,"marketCap":219073184},{"date":"2023-04-21","current":-10.705831,"twenty":-11.440849,"median":-9.236058,"eighty":-7.496152,"marketCap":204320781},{"date":"2023-04-28","current":-11.463355,"twenty":-11.463355,"median":-9.251266,"eighty":-7.496152,"marketCap":218778136},{"date":"2023-05-01","current":-12.211645,"twenty":-11.469477,"median":-9.25981,"eighty":-7.496152,"marketCap":233059240},{"date":"2023-05-12","current":-11.89369,"twenty":-11.658015,"median":-9.26808,"eighty":-7.496152,"marketCap":240145501},{"date":"2023-05-19","current":-13.141553,"twenty":-11.893853,"median":-9.303385,"eighty":-7.4981,"marketCap":265341095},{"date":"2023-05-26","current":-13.572736,"twenty":-12.376667,"median":-9.373083,"eighty":-7.505944,"marketCap":274047116},{"date":"2023-06-02","current":-13.905712,"twenty":-12.463106,"median":-9.391925,"eighty":-7.506147,"marketCap":280770234},{"date":"2023-06-09","current":-13.897784,"twenty":-12.70975,"median":-9.412549,"eighty":-7.506147,"marketCap":280610160},{"date":"2023-06-16","current":-14.42896,"twenty":-12.999339,"median":-9.452014,"eighty":-7.506147,"marketCap":291335135},{"date":"2023-06-23","current":-14.056344,"twenty":-13.239822,"median":-9.471747,"eighty":-7.514142,"marketCap":283811645},{"date":"2023-06-30","current":-12.954352,"twenty":-13.244502,"median":-9.481102,"eighty":-7.534132,"marketCap":261561324},{"date":"2023-07-07","current":-12.034704,"twenty":-13.213305,"median":-9.499475,"eighty":-7.55812,"marketCap":242992711},{"date":"2023-07-14","current":-12.082272,"twenty":-13.164951,"median":-9.548401,"eighty":-7.576348,"marketCap":243953157},{"date":"2023-07-21","current":-11.321184,"twenty":-13.104727,"median":-9.564908,"eighty":-7.580464,"marketCap":228586029},{"date":"2023-07-28","current":-11.154696,"twenty":-13.046317,"median":-9.586518,"eighty":-7.586105,"marketCap":225224469},{"date":"2023-08-04","current":-11.4956,"twenty":-13.024672,"median":-9.61481,"eighty":-7.589583,"marketCap":232107662},{"date":"2023-08-11","current":-11.568146,"twenty":-12.981344,"median":-9.64493,"eighty":-7.595321,"marketCap":258316695},{"date":"2023-08-18","current":-11.190253,"twenty":-12.938496,"median":-9.709283,"eighty":-7.5961,"marketCap":249878349},{"date":"2023-08-25","current":-11.167117,"twenty":-12.914712,"median":-9.749504,"eighty":-7.599235,"marketCap":249361716},{"date":"2023-09-01","current":-11.036011,"twenty":-12.870315,"median":-9.760327,"eighty":-7.612653,"marketCap":246434127},{"date":"2023-09-08","current":-11.151692,"twenty":-12.799405,"median":-9.777659,"eighty":-7.625726,"marketCap":249017293},{"date":"2023-09-15","current":-10.81236,"twenty":-12.778929,"median":-9.805813,"eighty":-7.625726,"marketCap":241440004},{"date":"2023-09-22","current":-10.550149,"twenty":-12.766059,"median":-9.8581,"eighty":-7.627797,"marketCap":235584825},{"date":"2023-09-29","current":-10.642694,"twenty":-12.754797,"median":-9.91491,"eighty":-7.636188,"marketCap":237651359},{"date":"2023-10-06","current":-8.38305,"twenty":-12.687226,"median":-9.900583,"eighty":-7.63662,"marketCap":187193498},{"date":"2023-10-13","current":-7.380477,"twenty":-12.582954,"median":-9.815398,"eighty":-7.63662,"marketCap":164806051},{"date":"2023-10-20","current":-6.994872,"twenty":-12.517778,"median":-9.787646,"eighty":-7.625726,"marketCap":156195494},{"date":"2023-10-27","current":-6.856054,"twenty":-12.500855,"median":-9.777659,"eighty":-7.617011,"marketCap":153095694},{"date":"2023-11-03","current":-7.295644,"twenty":-12.474627,"median":-9.75506,"eighty":-7.591323,"marketCap":162911728},{"date":"2023-11-10","current":-6.384789,"twenty":-12.465234,"median":-9.745482,"eighty":-7.564117,"marketCap":142597868},{"date":"2023-11-17","current":-6.361515,"twenty":-12.460749,"median":-9.701239,"eighty":-7.506147,"marketCap":142078070},{"date":"2023-11-24","current":-6.361515,"twenty":-12.450927,"median":-9.64493,"eighty":-7.496152,"marketCap":142078070},{"date":"2023-12-01","current":-6.594253,"twenty":-12.430299,"median":-9.61481,"eighty":-7.496152,"marketCap":147276049},{"date":"2023-12-08","current":-6.547705,"twenty":-12.335412,"median":-9.586518,"eighty":-7.486157,"marketCap":146236453},{"date":"2023-12-15","current":-6.625285,"twenty":-12.194779,"median":-9.564908,"eighty":-7.452843,"marketCap":147969112},{"date":"2023-12-22","current":-6.260661,"twenty":-12.140939,"median":-9.548401,"eighty":-7.432254,"marketCap":139825613},{"date":"2023-12-29","current":-6.648559,"twenty":-12.098128,"median":-9.517319,"eighty":-7.416193,"marketCap":148488910},{"date":"2024-01-05","current":-6.4934,"twenty":-12.093462,"median":-9.488582,"eighty":-7.408281,"marketCap":145023591},{"date":"2024-01-12","current":-7.54848,"twenty":-12.085504,"median":-9.474718,"eighty":-7.408281,"marketCap":168587759},{"date":"2024-01-19","current":-6.439094,"twenty":-12.082272,"median":-9.46188,"eighty":-7.391646,"marketCap":143810730},{"date":"2024-01-26","current":-5.996891,"twenty":-12.063245,"median":-9.451871,"eighty":-7.358883,"marketCap":133934571},{"date":"2024-02-02","current":-5.539173,"twenty":-12.010364,"median":-9.403927,"eighty":-7.324002,"marketCap":123711881},{"date":"2024-02-09","current":-5.345224,"twenty":-11.96331,"median":-9.373083,"eighty":-7.303747,"marketCap":119380232},{"date":"2024-02-16","current":-6.105503,"twenty":-11.93164,"median":-9.313568,"eighty":-7.27802,"marketCap":136360294},{"date":"2024-02-23","current":-5.787427,"twenty":-11.905064,"median":-9.279216,"eighty":-7.226222,"marketCap":129256391},{"date":"2024-03-01","current":-7.657092,"twenty":-11.893853,"median":-9.25981,"eighty":-7.201903,"marketCap":171013482},{"date":"2024-03-08","current":-8.110119,"twenty":-11.888595,"median":-9.239942,"eighty":-7.226222,"marketCap":180531251},{"date":"2024-03-15","current":-7.303897,"twenty":-11.863459,"median":-9.185622,"eighty":-7.234415,"marketCap":162584739},{"date":"2024-03-22","current":-7.224073,"twenty":-11.84433,"median":-9.144455,"eighty":-7.224117,"marketCap":160807857},{"date":"2024-03-28","current":-6.657322,"twenty":-11.84392,"median":-9.1187,"eighty":-7.196306,"marketCap":148191992},{"date":"2024-04-05","current":-6.154431,"twenty":-11.813935,"median":-9.096402,"eighty":-7.141402,"marketCap":136997633},{"date":"2024-04-12","current":-5.922941,"twenty":-11.807221,"median":-9.086347,"eighty":-7.106352,"marketCap":131844674},{"date":"2024-04-19","current":-5.364173,"twenty":-11.73344,"median":-9.082564,"eighty":-7.087417,"marketCap":119406497},{"date":"2024-04-26","current":-5.196543,"twenty":-11.725512,"median":-9.036485,"eighty":-7.056377,"marketCap":115675044},{"date":"2024-05-03","current":-5.5789,"twenty":-11.693997,"median":-9.020144,"eighty":-6.994872,"marketCap":124186324},{"date":"2024-05-10","current":-5.232404,"twenty":-11.670016,"median":-8.943064,"eighty":-6.926009,"marketCap":117111662},{"date":"2024-05-17","current":-5.355423,"twenty":-11.568146,"median":-8.86763,"eighty":-6.867017,"marketCap":119865071},{"date":"2024-05-24","current":-5.478442,"twenty":-11.551096,"median":-8.824241,"eighty":-6.807818,"marketCap":122618480},{"date":"2024-05-31","current":-5.248806,"twenty":-11.540057,"median":-8.78056,"eighty":-6.750346,"marketCap":117478784},{"date":"2024-06-07","current":-5.355423,"twenty":-11.535651,"median":-8.71467,"eighty":-6.643904,"marketCap":119865071},{"date":"2024-06-14","current":-5.601461,"twenty":-11.522593,"median":-8.700328,"eighty":-6.585481,"marketCap":125371889},{"date":"2024-06-21","current":-5.601461,"twenty":-11.514132,"median":-8.595282,"eighty":-6.550808,"marketCap":125371889},{"date":"2024-06-28","current":-5.14219,"twenty":-11.514103,"median":-8.591276,"eighty":-6.544445,"marketCap":115092496},{"date":"2024-07-05","current":-5.084781,"twenty":-11.509505,"median":-8.549205,"eighty":-6.524432,"marketCap":113807572},{"date":"2024-07-12","current":-5.248806,"twenty":-11.505115,"median":-8.477607,"eighty":-6.501158,"marketCap":117478784},{"date":"2024-07-15","current":-5.396429,"twenty":-11.504671,"median":-8.471907,"eighty":-6.499606,"marketCap":120782874},{"date":"2024-08-02","current":-5.068379,"twenty":-11.504226,"median":-8.439046,"eighty":-6.4934,"marketCap":113440450},{"date":"2024-08-09","current":-6.04608,"twenty":-11.4956,"median":-8.380128,"eighty":-6.446852,"marketCap":127584385},{"date":"2024-08-16","current":-5.568758,"twenty":-11.4956,"median":-8.33936,"eighty":-6.431336,"marketCap":117511934},{"date":"2024-08-23","current":-6.364295,"twenty":-11.487672,"median":-8.317646,"eighty":-6.400304,"marketCap":134299353},{"date":"2024-08-30","current":-6.001884,"twenty":-11.478815,"median":-8.282792,"eighty":-6.361515,"marketCap":126651751},{"date":"2024-09-06","current":-5.445008,"twenty":-11.472569,"median":-8.234715,"eighty":-6.361515,"marketCap":114900558},{"date":"2024-09-13","current":-5.745544,"twenty":-11.464886,"median":-8.172852,"eighty":-6.350611,"marketCap":121242472},{"date":"2024-09-20","current":-5.966527,"twenty":-11.457439,"median":-8.106128,"eighty":-6.299451,"marketCap":125905644},{"date":"2024-09-27","current":-5.445008,"twenty":-11.447214,"median":-8.0288,"eighty":-6.249174,"marketCap":114900558},{"date":"2024-10-04","current":-5.445008,"twenty":-11.428314,"median":-7.993998,"eighty":-6.196292,"marketCap":114900558},{"date":"2024-10-11","current":-5.471526,"twenty":-11.41595,"median":-7.975905,"eighty":-6.137667,"marketCap":115460138},{"date":"2024-10-18","current":-5.975366,"twenty":-11.389225,"median":-7.92057,"eighty":-6.076134,"marketCap":126092170},{"date":"2024-10-25","current":-7.734386,"twenty":-11.342169,"median":-7.870838,"eighty":-6.088277,"marketCap":163211020},{"date":"2024-10-31","current":-6.974207,"twenty":-11.32549,"median":-7.854682,"eighty":-6.099297,"marketCap":147169708},{"date":"2024-11-08","current":-8.029494,"twenty":-11.299815,"median":-7.828418,"eighty":-6.086567,"marketCap":155563417},{"date":"2024-11-15","current":-5.516667,"twenty":-11.283906,"median":-7.854682,"eighty":-6.086567,"marketCap":106879902},{"date":"2024-11-22","current":-4.886589,"twenty":-11.259662,"median":-7.803133,"eighty":-6.007187,"marketCap":94672767},{"date":"2024-11-29","current":-5.026205,"twenty":-11.229851,"median":-7.772793,"eighty":-5.982437,"marketCap":97377703},{"date":"2024-12-06","current":-4.746972,"twenty":-11.207233,"median":-7.743226,"eighty":-5.930799,"marketCap":91967831},{"date":"2024-12-13","current":-4.6273,"twenty":-11.199507,"median":-7.732114,"eighty":-5.891293,"marketCap":89649314},{"date":"2024-12-20","current":-4.677163,"twenty":-11.187168,"median":-7.695034,"eighty":-5.858687,"marketCap":90615363},{"date":"2024-12-27","current":-5.00626,"twenty":-11.179456,"median":-7.680195,"eighty":-5.833974,"marketCap":96991284},{"date":"2025-01-03","current":-5.375247,"twenty":-11.167117,"median":-7.680195,"eighty":-5.765486,"marketCap":104140044},{"date":"2025-01-10","current":-6.153113,"twenty":-11.15718,"median":-7.674115,"eighty":-5.765219,"marketCap":119210403},{"date":"2025-01-17","current":-5.445056,"twenty":-11.152293,"median":-7.657092,"eighty":-5.745544,"marketCap":105492512},{"date":"2025-01-24","current":-6.402428,"twenty":-11.143981,"median":-7.63662,"eighty":-5.743678,"marketCap":124040646},{"date":"2025-01-31","current":-6.721552,"twenty":-11.137297,"median":-7.62606,"eighty":-5.745544,"marketCap":130223358},{"date":"2025-02-07","current":-8.933023,"twenty":-11.094623,"median":-7.625726,"eighty":-5.756709,"marketCap":173068391},{"date":"2025-02-14","current":-8.575209,"twenty":-11.04835,"median":-7.63608,"eighty":-5.764953,"marketCap":166136094},{"date":"2025-02-21","current":-9.278499,"twenty":-11.027345,"median":-7.63662,"eighty":-5.774262,"marketCap":179761644},{"date":"2025-02-28","current":-8.442054,"twenty":-11.010673,"median":-7.657749,"eighty":-5.790095,"marketCap":160399020},{"date":"2025-03-07","current":-7.571459,"twenty":-11.00084,"median":-7.658407,"eighty":-5.794098,"marketCap":143857718},{"date":"2025-03-14","current":-10.279948,"twenty":-10.991897,"median":-7.680195,"eighty":-5.810034,"marketCap":195319016},{"date":"2025-03-21","current":-11.51108,"twenty":-11.024301,"median":-7.680195,"eighty":-5.833952,"marketCap":218710515},{"date":"2025-03-28","current":-11.880419,"twenty":-11.05452,"median":-7.709402,"eighty":-5.833974,"marketCap":225727965},{"date":"2025-04-04","current":-11.14174,"twenty":-11.147711,"median":-7.734386,"eighty":-5.837495,"marketCap":211693065},{"date":"2025-04-11","current":-10.495396,"twenty":-11.14058,"median":-7.744393,"eighty":-5.846312,"marketCap":199412528},{"date":"2025-04-17","current":-10.710844,"twenty":-11.149702,"median":-7.758662,"eighty":-5.855152,"marketCap":203506041},{"date":"2025-04-25","current":-13.493202,"twenty":-11.164633,"median":-7.795998,"eighty":-5.871062,"marketCap":256370829},{"date":"2025-05-02","current":-11.843485,"twenty":-11.207752,"median":-7.810247,"eighty":-5.879113,"marketCap":225026220},{"date":"2025-05-05","current":-11.387967,"twenty":-11.229851,"median":-7.810268,"eighty":-5.880092,"marketCap":216371365}],"updateTime":1746588529273}}}